The application of immunologic advances regarding B cell activation to the understanding of the human IgE antibody response has been hampered by the lack of reproducible in vitro models for the induction of IgE synthesis (1-3). Recently, Lanzavecchia (4) has reported that human alloreactive T cell clones can induce IgE secretion by human B cells. However, their study did not characterize the allergic status of the B cell donors. B cells from allergic donors differ from normal B cells in that they spontaneously secrete IgE (1-3, 5, 6). Because of this, B cells from allergic vs. normal subjects are likely to differ in their requirements for the induction of IgE synthesis in vitro. The delineation of these differences has important implications for the understanding of the human allergic response.
determined by a PRIST assay; Pharmacia, Inc., Uppsala, Sweden). Three adult allergic subjects wit h positive histories of allergic disease (e.g., seasonal allergic rhinitis, extrinsic asthma, and eczema) and with elevated serum IgE levels (>400 IU/ml) were also studied. Written consent was obtained from all subjects before the study. Peripheral blood mononuclear cells (PBMC) ~ from donors were HLA-DR typed in a standard microcytotoxicity assay by the Histocompatibility Lab at the Dana Farber Cancer Institute, Boston.
Isolation of Mononuclear Cell
Subpopulations. PBMC were isolated from the blood of healthy donors by flotation over Ficoll-Hypaque, and washed three times with Hanks' balanced salt solution.
B Cells. T cells were depleted from PBMC by rosette formation with aminoethylisothioronium (AET)-treated sheep cells. E rosette-negative cells were enriched by flotation over FicolI-Hypaque. In some experiments, E rosette-negative cells were further purified by treatment with OKT3 (Ortho Pharmaceutical, Raritan, NJ) and complement (PelFreeze Biologicals, Rogers, AR) to remove residual T cells.
Preparation of Monocytes. PBMC were incubated overnight in petri dishes at 37°C in media containing 10% AB+ serum. In some experiments the PBMC were pulsed overnight with tetanus toxoid, 50 #g/ml. Nonadherent cells were then removed, and the remaining adherent cells were washed with warm media. Ice-cold phosphate-buffered saline (PBS) was added to the dishes, and the monocytes were aspirated and resuspended in RPMI 1640. Monocytes were irradiated (2,500 rad) before being added to 96-weU plates (2 x 104 cells per well).
Preparation of T Cell Clones. T lymphocyte clones with specificity for tetanus toxoid
(TT) and/or alloantigens were produced as previously described (7) . Two clones were used. Clone F6 is a TT-specific clone that is restricted by HLA-DR3 and shows limited alloreactivity (7) . G8 is a TT-specific clone restricted by HLA-DR5. These clones were derived from an HLA-DR3,5 donor as follows. 10 x 106 PBMC were suspended in 10 ml RPMI 1640 (M. A. Bioproducts, Walkersville, MD) containing 10% AB+ serum (complete medium) and stimulated with TT at 30 #g/ml. After incubation at 37°C in 5% CO2 for 6 or 7 d, the cultures were harvested and dividing cells were enriched by centrifugation over a Percoll (Pharmacia, Inc.) discontinuous gradient at 1,500 rpm for 45 min. Cells at the 30-50% interface were resuspended in complete medium supplemented with 25% interleukin 2-containing supernatants (IL-2 SN) that contained irradiated (2,500 rad) autologous PBMC plus TT and were distributed in 96-well trays (Nunc, Roskilde, Denmark). Each 0.2 ml well contained an average of 0.3 blast and 105 irradiated PBMC. After 14-21 d of culture, cells were transferred to 24-well trays (Linbro Scientific Co., Hamden, CT). Clones have been maintained in culture for > 1 yr with repeated stimulation with antigen (TT and autologous PBMC) and IL-2 SN. T cell clones were extensively subcloned by limiting dilution at 0.3 cell per well.
IL-2 SN. PBMC were obtained from donors previously screened for their capacity to generate high activity IL-2. PBMC were depleted of monocytes by adherence to plastic petri dishes and the nonadherent cells were irradiated (1,000 rad). Cells were suspended at 106 cells/ml in RPMI 1640 with 2% AB+ serum containing phytohemagglutinin (1 ~g/ ml; Burroughs Wellcome Co., Research Triangle Park, NC), and harvested after 48 h.
Immunoglobulin Synthesis in Cell Cultures. The cell culture system used for the induction of immunoglobulin synthesis was performed in 96-well microtiter plates, in RPMI 1640 medium containing 10% fetal calf serum in a humidified atmosphere of 5% CO2 in air. Each microtiter well contained the following: (a) E rosette-negative cells (B cells), I x 105/well; (b) irradiated (2,500 rad) monocytes (to activate the T cell clones), 2 x 104/ well; (c) irradiated (2,500 rad) cloned T cells, 4 x 104/well, when indicated. After 96 h of culture the cells were washed twice with culture medium. This washing step was done to remove IgE released in the first 4 d of culture. Fresh medium was added, and cultures were incubated for an additional 8 d in the presence or absence of the protein synthesis Abbreviations used in this paper: ELISA, enzyme-linked immunosorbent assay; HS, horse serum; IL-2, interleukin 2; PBMC, peripheral blood monom/clear cells; PBS, phosphate-buffered saline; PWM, pokeweed mitogen; RIA, radioimmunoassay; SN, supernatant; TT, tetanus toxoid. inhibitor cycloheximide (100 ug/ml). SN were harvested from duplicate cultures and assayed for immunoglobulin (IgE, IgG, IgA, IgM) content.
Acid Treatment of Cultured Cells.
To determine the amount of IgE associated with the cells, we acid-treated the cells at days 0 and 4 after washing, as described by Turner et al. (8) . 5 × 105 E rosette-negative B cells with 105 irradiated adherent cells were pelleted in 5-ml tubes. The cells were resuspended in 0.4 ml of 0.01 M glycine buffer, pH 2, for 1 min. 0.6 ml of 0.15 M PBS, pH 7.4, was added to obtain a final pH of 7 and a final volume of 1 ml. The SN were then collected and assayed for IgE.
Radioimmunoassay (RIA)for IgE. Duplicate samples from each culture were analyzed for their IgE content. The RIA for IgE was performed in flexible flat-bottom microtiter plates (Becton, Dickinson & Co., Oxnard, CA). The wells were filled with 0.1 ml of a 10 t~g/ml solution containing a 1:1 mixture of two monoclonal anti-human IgE, Fc-specific antibodies (monoclonal antibodies 8 and 9). After incubation for 16 h, the coating solution was removed, and the wells were washed and blocked with 10% horse serum (HS) in PBS for 2 h. After washing three times with PBS containing 1% HS, we added 0.1 ml of culture SN or of IgE standard to each of the triplicate wells and incubated them for 16 h in a humidified chamber at room temperature. The wells were then washed twice with PBS, 1% HS containing 0.5% Tween 20 and twice with PBS, 1% HS alone; then 0.1 ml of Phadebas RAST ~SI-anti-human IgE (ND) (Pharmacia, Inc.; sp act, 12 #Ci/t~g) was added to each well. 6 h later the radiolabeled anti-IgE was removed and wells were washed three times with PBS, 1% HS and eight times under running distilled water. The wells were cut out and counted in a gamma spectrometer (TM Analytic, Inc., Elk Grove, IL). Standard curves were constructed using dilutions of the IgE standards obtained from Pharmacia, Inc. The concentration of IgE in the SN was read from the standard curve. Results were expressed as the mean of duplicate determinations of duplicate cultures. The lower limit of sensitivity of this assay was 100-200 pg/ml.
The specificity and sensitivity of our IgE RIA was confirmed in a recently completed multi-institutional study coordinated by the Mayo Clinic (Drs. Yunginger, Helm and Gleich; manuscript in preparation). Coded samples with varying quantities of polyclonal IgE in the presence of other immunoglobulin isotypes sent to our laboratory were evaluated using our IgE RIA. In no test sample did we measure falsely elevated IgE values, thus ruling out the possibility of crossreactivity with other isotypes. Furthermore, values of IgE >300 pg/ml were measured accurately within 10% of expected values.
Enzyme-linked lmmunosorbent Assays (ELISA) of SN for IgG, IgA, and lgM. 96-well polystyrene plates were coated with immunoabsorbed, purified goat anti-IgG, anti-IgA, or anti-IgM (Tago, Inc., Burlingame, CA) (10 /tg/ml). After washing with PBS, 0.1% Tween 20, the plates were incubated with a 0.1% gelatin solution for 1 h and washed, and 0.1 ml of appropriately diluted SN were added to the wells. After 18 h the plates were again washed, and horseradish peroxidase-conjugated anti-IgG, -IgA, or -IgM was added (1:3000). The plates were incubated for 1 h at 37 °C and washed, and the bound, tagged antibody was quantitated using the substrate, azino-diethyl-benzthiazoline sulfonic acid. Plates were incubated with the substrate for 30 min, and the absorbance at 414 nm was read on a Titertek Multiskan Spectrophotometer (Flow Laboratories, Inc., McLean, VA). Standard curves were performed using purified Ig (Kallestad Laboratories, Austin, TX). The specificity of the conjugated antisera was ascertained by testing in a direct ELISA against purified human myeloma G,M,A and kappa and lamda Bence Jones proteins.
Results

Induction of IgE Synthesis by Alloreactive T Cell Clones.
The characteristics of the T cell clones used in this study are shown in Table I . Both clones were T4 +. Clone F6 exhibited both alloreactivity and reactivity to TT antigen (described in detail in reference 7). The alloreactivity of F6 is preferentially but not exclusively directed to HLA-DR4 + cells. F6 proliferated in response to stimulation with 13 of 14 HLA-DR4 ÷ cells and 3 of 18 of HLA-DR4-cells. F6 also proliferated to TT presented by HLA-DR3 + accessory cells. Clone G8 is a TTspecific clone that exhibited no alloreactivity against a panel of 10 randomly chosen donors. G8 proliferated to TT presented by HLA-DR5 + cells (7) . The characteristics of the nine adult donors whose B cells were used in this study are shown in Table II . These characteristics include allergic status, serum IgE, HLA-DR phenotype, and their cells' ability to stimulate F6. Table III depicts an experiment in which the ailoreactive clone F6 was used to induce Ig synthesis in B cells obtained from two donors, one allergic and one nonallergic. Cells from both donors were known to be capable of stimulating the F6 proliferation. In the presence of irradiated, cloned F6 cells, polyclonal Ig, including IgE, synthesis was induced in B cells of both donors (Table III) . Spontaneous IgE synthesis could be detected only in cultures of B cells from the allergic and not the nonallergic subject. Pokeweed mitogen (PWM) (Sigma Chemical Co., St. Louis, MO), in the presence of added autologous T cells, failed to induce IgE synthesis in B cell cultures of both subjects in spite of PWM's capacity to cause vigorous synthesis of IgM, IgA, and IgG isotypes. Calculation oflgE Synthesis. In the present experiments we have minimized the contribution of preformed IgE to our measurement of IgE synthesis. Cultures were washed on day 4 to remove IgE released into the SN in the first 4 d in culture. Acid elution of the cell pellets at days 0 and 4 showed that, by day 4, IgE associated with the cell pellet had become undetectable (Fig. 1) presumably because it was released into the culture supernatant. The day-4 washed cells were then incubated for eight more days in the presence or absence of cycloheximide. Fig. 2 
in contrast to B cells from allergic donors, B cells from normal donors were induced to synthesize IgE only under conditions of cognate interaction with F6 (donors DL, MS, SY). Bystander normal B cells that did not
express alloantigens capable of stimulating F6 synthesized no IgE in the presence of F6 and third-party allostimulator monocytes (Table V, donors RG, RF, NW). In the same cultures, the normal bystander B cells from these three donors were induced to synthesize IgG. Thus, the failure of normal B cells to synthesize IgE under conditions of noncognate interaction was IgE isotype specific and was not due to lack of activation of F6. Failure of bystander normal B cells to synthesize IgE occurred even when the donor of B cells shared a common HLA-DR determinant (HLA-DR3 or HLA-DR5) with the donor of the T cell clone. Thus, mere sharing of HLA-DR determinants by the clone and by B cells was not sufficient to activate the B cells into IgE synthesis.
The induction of IgE in bystander B cells from allergic donors but not from normal donors was not restricted to alloreactive clones. Table VI shows that similar data was obtained when B cells were cultured with irradiated T cells from the TT-specific clone G8 in the presence of TT-pulsed, HLA-DR5 ÷ third-party monocytes known to activate G8. IgE synthesis in these cultures was induced in B cells from allergic donors, but not in B cells from nonallergic donors, whereas IgG synthesis was induced in B cells from all donors. (Table VII) synthesized equivalent amounts of IgE as non OKT3 plus C'-treated B cell populations when stimulated with cloned T cells. This was regardless of whether the stimulus was delivered by cognate or noncognate bystander interaction. Culture conditions are similar to those described in Table IV . E rosette-negative cells were incubated with OKT3 at 0°C as indicated. After 40 rain at 0°C, baby rabbit complement was added. After 30 min incubation at 37°C, the cells were washed and then placed in culture (1 × 105/well). Clone F6 was stimulated by alloantigens expressed by the B cell donor. Clone G8 was stimulated by the addition of HLA-DR5 +, TT-pulsed monocytes.
Role of Residual T Cells on Induction of lgE Synthesis in B Cells. The induction of IgE synthesis in B cell cultures by cloned T cells was unlikely to have been mediated by residual T cells that contaminated the B cell-enriched populations. B cell-enriched populations from allergic subjects vigorously depleted of residual T cells by treatment with OKT3 and complement
Role of Antigen Recognition by T Cells in B Cell Activation. It is important to
Effect of Residual T Cells on Induction of lgE Synthesis in B Cell Cultures by T Cell Clones
emphasize that, in the absence of T cell recognition of antigen, no activation signal was delivered to the B cells. When B cells from a normal subject whose cells did not stimulate clone F6 proliferation were cultured with F6 (Table VIII) , neither IgE nor IgG was secreted. Only when HLA-DR4 + third-party monocytes were added to the culture were the normal B cells stimulated to secrete IgG, but Culture conditions are similar to those described in Table IV . HLA-DR5 +, TT-pulsed monocytes (2,500 rad irradiated) functioned as stimulator cells for G8. HLA-DR4 ÷ monocytes (2,500 rad irradiated) functioned as stimulator ceils for F6.
not IgE, via a bystander interaction. When B cells from an allergic subject were cultured with clone G8, neither IgG nor IgE synthesis was induced unless TTpulsed HEA-DR5 + monocytes were added to activate clone G8. Discussion The present study demonstrates that de novo IgE synthesis can be induced in B cells of allergic as well as normal subjects under conditions of cognate interaction by an alloreactive clone. Furthermore, B cells from allergic but not from normal donors synthesized IgE when present as bystanders in cultures containing alloactivated or antigen-activated cloned T cells.
Until recently, the study of human IgE synthesis has been limited to the spontaneous IgE secretion by B cells from allergic individuals (1-3, 5, 6 ). In our hands and those of several other investigators (1, 2), polyclonal B cell activators, such as PWM, have failed to induce IgE synthesis in peripheral blood B cells of both normal and allergic donors. The unique ability of T cell clones to induce IgE synthesis in B cells from normal donors may relate to several observations. First, these clones are more powerful polyclonal activators than PWM in that they cause better production of IgG and IgM (Table III) and activate a higher frequency of B cells (4) . Second, T cell clones activate both small as well as large B cells (9, 10) whereas PWM appears to activate only large B cells that are thought to represent B cells preactivated in vivo. Finally, helper T cell clones provide helper activity for Ig synthesis in the absence of suppressor T cells. In murine systems, interactions of unfractionated T cells with aliogeneic B cells have been reported to induce IgG synthesis and suppress IgE synthesis (1 1). It is likely that IgE synthesis is uniquely sensitive to suppressor signals generated by unfractionated T cells responding in a mixed lymphocyte reaction. The differential sensitivity of the IgE vs. IgG antibody response to suppressor signals has been well documented (12) .
Although, in the present study, we used a single alloreactive T cell clone, F6, to induce IgE synthesis, this phenomenon is not limited to clone F6. Indeed, Lanzavecchia (4) (Table IV) . Normal B cells that lacked the stimulatory alloantigens made no IgE in the presence of alloreactive T cells stimulated by third-party monocytes bearing the appropriate alloantigens. This observation makes it likely that the induction of IgE synthesis in normal B cells bearing the stimulating alloantigens actually involves direct recognition of these antigens by the T cell on the B cell surface, rather than bystander activation resulting from recognition of the alloantigens on the surface of monocytes in the B cell-enriched populations. Thus, direct T-B cell interaction via T cell recognition of B cell surface alloantigen appears to be required for IgE induction in normal B ceils.
Recently, Nutman et al. (14) , using filariai parasite-specific T cell lines or their SN, were able to induce IgE synthesis in B cells from nonatopic B cells. They found, however, that SN from helper T cell lines raised against a nonparasite antigen did not induce IgE production, perhaps indicating that the parasite antigen was critical for the induction of IgE synthesis in their system. The antigen-specific clone used in our study (clone G8) was directed against TT, a nonparasite antigen. Neither this nor other TT-specific clones (data not shown) induced IgE synthesis in normal B cells.
In contrast to the requirement for cognate interaction for the induction of IgE synthesis in normal B cells, induction of IgG synthesis in the same B cells occurred both under conditions of cognate interaction and bystander activation. Our finding that T cell clones provide major histocompatibility complex-unrestricted help for IgG synthesis by human B cells confirms and extends the reports of others (4, 15) . The reason for the differential response of IgG and IgE synthesis to bystander stimulation of normal B cells may relate to the in vivo activation status of B cells committed, respectively, to IgG and IgE synthesis in normal subjects. The lack of spontaneous IgE synthesis by normal circulating B cells suggests that few if any IgE B cells circulate in an activated state in normal nonallergic subjects. On the other hand, B cells from normal individuals spontaneously produce IgG. The majority of the in vivo activated B cells that spontaneously secrete IgG have been shown to reside in the less dense fractions of a density gradient, to be large, and to respond to T cell-dependent, PWMtriggered activation (i 6) and to T cell-derived factors (17) .
In contrast to normal B cells, B cells from allergic subjects responded to bystander stimulation by synthesizing IgE (Table IV) . This response is consistent with the presence in these individuals of circulating, activated IgE B cells that synthesize IgE spontaneously. These secreting IgE cells were recently shown (18) to be relatively large and to respond to T cell-derived, IgE-binding factors by enhancing their IgE synthesis.
Several 
